Loading data
CRVONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.01 m USD | 9.74 m USD | 7.14 m USD | 0 USD | — |
| Research and development expense | 21.82 m USD | 18.8 m USD | 8.44 m USD | 1.34 m USD | 8.5 m USD |
| Operating profit | -28.29 m USD | -18.23 m USD | -7.81 m USD | -3.48 m USD | -24.68 m USD |
| Interest expense | — | — | 0 USD | 587 USD | — |
| Profit before tax | — | — | — | -15.59 m USD | -24.54 m USD |
| Income tax expense | 0 USD | — | — | 0 USD | -400 k USD |
| Net income (reported basis) | -26.97 m USD | -16.29 m USD | -2.17 m USD | -5.8 m USD | -24.1 m USD |
| Basic earnings per share | -2.98 USD/share | -2.02 USD/share | -0.82 USD/share | -11.2 USD/share | -12.38 USD/share |
| Diluted earnings per share | — | — | — | 2,038,891 USD/share | 1,946,859 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.